| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.11 | 4e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |